Repligen Corp (RGEN)
141.76
+2.86
(+2.06%)
USD |
NASDAQ |
Nov 21, 16:00
141.20
-0.56
(-0.40%)
Pre-Market: 09:06
Repligen Debt to Equity Ratio: 0.2586 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.2586 |
June 30, 2024 | 0.2956 |
March 31, 2024 | 0.2961 |
December 31, 2023 | 0.295 |
September 30, 2023 | 0.1438 |
June 30, 2023 | 0.1449 |
March 31, 2023 | 0.1469 |
December 31, 2022 | 0.149 |
September 30, 2022 | 0.1548 |
June 30, 2022 | 0.1571 |
March 31, 2022 | 0.1604 |
December 31, 2021 | 0.1459 |
September 30, 2021 | 0.1471 |
June 30, 2021 | 0.1556 |
March 31, 2021 | 0.1584 |
December 31, 2020 | 0.1594 |
September 30, 2020 | 0.2142 |
June 30, 2020 | 0.2165 |
March 31, 2020 | 0.2201 |
December 31, 2019 | 0.2196 |
September 30, 2019 | 0.2202 |
June 30, 2019 | 0.1203 |
March 31, 2019 | 0.1673 |
December 31, 2018 | 0.1681 |
September 30, 2018 | 0.1688 |
Date | Value |
---|---|
June 30, 2018 | 0.1693 |
March 31, 2018 | 0.1679 |
December 31, 2017 | 0.1678 |
September 30, 2017 | 0.1703 |
June 30, 2017 | 0.5092 |
March 31, 2017 | 0.5444 |
December 31, 2016 | 0.5645 |
September 30, 2016 | 0.5664 |
June 30, 2016 | 0.5704 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1438
Minimum
Sep 2023
0.2961
Maximum
Mar 2024
0.1919
Average
0.1589
Median
Debt to Equity Ratio Benchmarks
West Pharmaceutical Services Inc | 0.0736 |
QuidelOrtho Corp | 0.8003 |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | 0.7605 |
Catheter Precision Inc | 0.1364 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 2.831B |
Total Liabilities (Quarterly) | 813.96M |
Shareholders Equity (Quarterly) | 2.017B |
Current Ratio | 10.44 |
Net Debt Paydown Yield | -0.57% |